Detalhe da pesquisa
1.
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC study.
Ann Hematol
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38568260
2.
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.
Ann Hematol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438627
3.
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis.
Am J Hematol
; 99(4): 755-758, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291566
4.
Treatment-free remission after dasatinib in patients with chronic myeloid leukaemia in chronic phase with deep molecular response: Final 5-year analysis of DASFREE.
Br J Haematol
; 202(5): 942-952, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246588
5.
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study.
J Med Virol
; 95(7): e28933, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403897
6.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407542
7.
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Hematol Oncol
; 41(4): 753-761, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081742
8.
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.
Ann Hematol
; 102(2): 447-456, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422672
9.
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Cancer
; 128(13): 2441-2448, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417564
10.
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Ann Hematol
; 101(10): 2231-2239, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36042023
11.
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
Am J Hematol
; 97(1): 30-42, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34695229
12.
Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia.
Br J Haematol
; 192(6): 988-996, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745264
13.
Cardiovascular Oncology: The Need for a Multidisciplinary Approach.
Semin Thromb Hemost
; 47(8): 907-913, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154001
14.
Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry.
Am J Hematol
; 96(10): 1186-1194, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152630
15.
Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model.
Biol Blood Marrow Transplant
; 26(12): 2237-2244, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717433
16.
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.
Ann Hematol
; 99(4): 791-798, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32086587
17.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Ann Hematol
; 98(2): 321-330, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30446802
18.
Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre. / Trasplante de precursores hematopoyéticos en enfermedad de Crohn refractaria: experiencia en nuestro centro.
Gastroenterol Hepatol
; 42(1): 16-22, 2019 Jan.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-30337206
19.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
Br J Haematol
; 200(6): e58-e61, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652997
20.
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Ann Hematol
; 97(11): 2089-2098, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955943